Research Article

Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway

Figure 5

Results of qRT-PCR and western blot. (a) After treatment with meloxicam, the expression of PD-L1 on the surface of YY8103 and Hep3B cells increased. (b) After treatment with meloxicam, the change of expression of CD155 on the surface of YY8103 and Hep3B cells. (c) The result of western blot after treatment with meloxicam. (d) After treatment with meloxicam, the expression of microRNA-200 of YY8103 and Hep3B cells downregulated. (e) After treatment with meloxicam, the expression of microRNA-513 of Hep3B cells. ; ; ; .
(a)
(b)
(c)
(d)
(e)